Enveric Biosciences, Inc. Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Enveric Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Enveric Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$2.08M, a 39.6% increase year-over-year.
  • Enveric Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$8.84M, a 66.4% increase year-over-year.
  • Enveric Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$16.4M, a 40% increase from 2022.
  • Enveric Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$27.4M, a 57.6% increase from 2021.
  • Enveric Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$64.6M, a 1050% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.